Experiment 356001
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Serenoa repens (ARECACEAE) |
| Citation | KONDAS,J: PHILIPP,V: DIOSZEGLY,G:. (1997). SABAL SERRULATA EXTRACT IN THE MANAGEMENT OF SYMPTOMS OF PROSTATIC HYPERTROPHY.. 138(7) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE EFFECTIVENESS OF A STANDARDIZED SERENOA EXTRACT ON THE SYMPTOMS OF PROSTATIC HYPERPLASIA IN 38 PATIENTS WAS MEASURED DURING A 12-MONTH CONTROLLED CLINICAL TRIAL. TREATMENT DECREASED SUBJECTIVE SYMPTOMS IN THREE FOURTH OF PATIENTS WITH NO SIDE EFFECTS REPORTED. PEAK FLOW VALUES INCREASED FROM 10.36 TO 14.44 ML/SEC AND RESIDUAL URINE VOLUME DECREASED. |
| Dose amount | 320.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HEXANE EXT |
| Gender | MALE |